HPA-suppressive effects of aqueous clobetasol propionate in the treatment of patients with oral lichen planus

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 9, 2010, Pages 1055-1059

  Gonzalez Moles, M A ^a   Scully, C ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

clobetasol propionate; corticosteroid; hypothalamus pituitary adrenal axis; lichen planus; oral

Indexed keywords

CLOBETASOL PROPIONATE; CORTICOTROPIN; HYDROCORTISONE; NYSTATIN;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STIMULATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LICHEN PLANUS, ORAL; PITUITARY-ADRENAL SYSTEM; RETROSPECTIVE STUDIES;

EID: 77955258154     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03591.x     Document Type: Article

References (25)

1. Gonzalez-Moles MA, Morales P, Rodriguez-Archilla A, Isabel IR, Gonzalez-Moles S. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002 93 : 264 270.
2. Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 95 : 688 692.
3. Gonzalez-Moles MA, Scully C. Vesiculo-erosive oral mucosal disease - management with topical corticosteroids: (1) Fundamental principles and specific agents available. J Dent Res 2005 84 : 294 301. (Pubitemid 43822008)
4. Gonzalez-Moles MA, Scully C. Vesiculo-erosive oral mucosal disease-management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future. J Dent Res 2005 84 : 302 308.
5. Baid SK, Nieman LK. Therapeutic doses of glucocorticosteroids: implications for oral medicine. Oral Dis 2006 12 : 436 442.
6. Axelrod L. Glucocorticosteroid therapy. Medicine (Baltimore) 1976 55 : 39 65.
7. Reimondo G, Bovio S, Allasino B, Terzolo M, Angeli A. Secondary hypoadrenalism. Pituitary 2008 11 : 147 154.
8. Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998 38 : 318 321.
9. Nathan AW, Rose GL. Fatal iatrogenic Cushing's syndrome. Lancet 1979 1 : 207.
10. Sneddon IB. The noxious effects of steroids in local application. Bull Soc Fr Dermatol Syphiligr 1970 77 : 670 672.
11. Carbone M, Conrotto D, Carrozzo M, Bronccoletti R, Gandolfo S, Scully C. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999 5 : 44 49.
12. Conrotto D, Carbone M, Carrozzo M et al. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 2006 154 : 139 145.
13. Allenby CF, Main RA, Marsden RA, Sparkes CG. Effect on adrenal function of topically applied clobetasol propionate (Dermovate). Br Med J 1975 13 : 619 621.
14. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med 2002 13 : 390 396.
15. van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003 32 : 507 512.
16. van der Meij EH, Reibel J, Slootweg PJ, van der Wal JE, de Jong WF, van der Waal I. Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med 1999 28 : 274 277.
17. van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 307 310.
18. Grispoon SK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994 9 : 923 931.
19. Speckart PF, Nicoloff JT, Bethune JE. Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med 1971 128 : 761 763.
20. May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Am J Med 1985 79 : 679 684.
21. Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000 85 : 3713 3719.
22. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002 287 : 236 240.
23. Key SJ, Hodder SC, Davies R, Thomas DW, Thompson S. Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update 2003 30 : 316 320.
24. Gibson N, Ferguson JW. Steroid cover for dental patients on long-term steroid medication: proposed clinical guidelines based upon a critical review of the literature. Br Dent J 2004 197 : 681 685.
25. Ohman EM, Rogers S, Meenan FO, McKenna TJ. Adrenal suppression following low-dose topical clobetasol propionate. J R Soc Méd 1987 80 : 422 424.